NCT05922696View on ClinicalTrials.gov

Cholecalciferol Supplementation in Hemodialysis Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 15, 2022

Primary Completion Date

September 15, 2022

Study Completion Date

January 26, 2023

Conditions
AnemiaHemodialysis ComplicationVitamin D Deficiency
Interventions
DRUG

Cholecalciferol

50.000IU weekly in Group A , or 200.000IU monthly in Group B

Trial Locations (1)

Unknown

Ain Shams University Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER